$5.19-0.06 (-1.14%)
Sono-Tek Corporation designs and manufactures ultrasonic coating systems for applying on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and research and development/other markets.
Sono-Tek Corporation in the Technology sector is trading at $5.19 with a market capitalization of $82M. Wall Street consensus targets $7.50 (2 analysts), implying a +44.5% move over the next 12 months. The stock is currently 17% below its 52-week high of $6.24, remaining 16.1% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $5.66M↑ | $5.61M↑ | $5.00M↓ | $5.16M↑ | $5.13M |
| Gross Profit | $3.21M↑ | $2.79M↑ | $2.51M↓ | $2.59M↓ | $2.66M |
| Operating Income | $897,160↑ | $601,475↑ | $318,972↓ | $421,154↓ | $483,368 |
| Net Income | $741,168↑ | $557,044↑ | $339,959↓ | $423,693↓ | $484,985 |
Sono-Tek Corporation designs and manufactures ultrasonic coating systems for applying on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and research and development/other markets. The company offer...
SonoTek (SOTK) delivered earnings and revenue surprises of 0.00% and -0.68%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?
SonoTek (SOTK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Sono-Tek Corp (SOTK) reports robust financial performance with significant growth in the medical sector, despite facing headwinds in clean energy and industrial markets.
Moby summary of Sono-Tek Corporation's Q4 2026 earnings call
Sono-Tek (NASDAQ:SOTK) reported higher profitability and modest revenue growth for fiscal 2026, as management said the company’s shift toward larger, higher-value production systems continued to support margins and earnings. On the company’s fiscal 2026 earnings call, Executive Chairman Dr. Christo